The mammalian molybdenum enzymes of mARC. (Q38271482)

1 September 2017

1 reference

title

The mammalian molybdenum enzymes of mARC. (English)

1 reference

1 September 2017

Gudrun Ott

1

1 reference

1 September 2017

Antje Havemeyer

series ordinal

2

1 reference

1 September 2017

Bernd Clement

series ordinal

3

1 reference

1 September 2017

publication date

26 November 2014

1 reference

Journal of Biological Inorganic Chemistry

1 September 2017

published in

1 reference

1 September 2017

volume

20

1 reference

1 September 2017

issue

2

1 reference

1 September 2017

page(s)

265-275

1 reference

Characteristics of Nicotiana tabacum nitrate reductase protein produced in Saccharomyces cerevisiae

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Molybdoproteomes and evolution of molybdenum utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The Mononuclear Molybdenum Enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The Chlamydomonas reinhardtii molybdenum cofactor enzyme crARC has a Zn-dependent activity and protein partners similar to those of its human homologue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The mononuclear molybdenum enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The fourth mammalian molybdenum enzyme mARC: current state of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Biochemical and spectroscopic characterization of the human mitochondrial amidoxime reducing components hmARC-1 and hmARC-2 suggests the existence of a new molybdenum enzyme family in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The mitochondrial amidoxime-reducing component (mARC1) is a novel signal-anchored protein of the outer mitochondrial membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Molybdenum enzymes in higher organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

YcbX and yiiM, two novel determinants for resistance of Escherichia coli to N-hydroxylated base analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Binding of sulfurated molybdenum cofactor to the C-terminal domain of ABA3 from Arabidopsis thaliana provides insight into the mechanism of molybdenum cofactor sulfuration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

ABA3 is a molybdenum cofactor sulfurase required for activation of aldehyde oxidase and xanthine dehydrogenase in Arabidopsis thaliana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Coordination chemistry at the molybdenum site of sulfite oxidase: redox-induced structural changes in the cysteine 207 to serine mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Structural studies of the molybdenum center of mitochondrial amidoxime reducing component (mARC) by pulsed EPR spectroscopy and 17O-labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Molybdenum site structure of MOSC family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

A gene atlas of the mouse and human protein-encoding transcriptomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Glucose regulation of CDK7, a putative thiol related gene, in experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The mitochondrial Amidoxime Reducing Component (mARC) is involved in detoxification of N-hydroxylated base analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Proteomic analysis of the mouse liver mitochondrial inner membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

A mitochondrial protein compendium elucidates complex I disease biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Amidoxime reductase system containing cytochrome b5 type B (CYB5B) and MOSC2 is of importance for lipid synthesis in adipocyte mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Rat liver peroxisomes after fibrate treatment. A survey using quantitative mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Peroxisome assembly and functional diversity in eukaryotic microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Targeting signals in peroxisomal membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

A micropreparation of mitochondria from cells using magnetic beads with immunoaffinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Role of Thr(66) in porcine NADH-cytochrome b5 reductase in catalysis and control of the rate-limiting step in electron transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Targeting of a tail-anchored protein to endoplasmic reticulum and mitochondrial outer membrane by independent but competing pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

NITRATE REDUCTASE STRUCTURE, FUNCTION AND REGULATION: Bridging the Gap between Biochemistry and Physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Reduction of N-hydroxy-sulfonamides, including N-hydroxy-valdecoxib, by the molybdenum-containing enzyme mARC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Activation of the anti-cancer agent upamostat by the mARC enzyme system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Structural basis of eukaryotic nitrate reduction: crystal structures of the nitrate reductase active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Protease inhibitors in the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Inhibitors of Factor VIIa/tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Antibacterial action of some aromatic amines, amidines, amidoximes, guanidines and diguanidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Dual molecules as new antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Diamidine activity against trypanosomes: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Reduction of N-hydroxylated compounds: amidoximes (N-hydroxyamidines) as pro-drugs of amidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Prodrugs: design and clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

New direct thrombin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Diacetyldiamidoximeester of pentamidine, a prodrug for treatment of protozoal diseases: synthesis, in vitro and in vivo biotransformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Prodrugs for amidines: synthesis and anti-Pneumocystis carinii activity of carbamates of 2,5-bis(4-amidinophenyl)furan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Characterization of in Vitro Biotransformation of New, Orally Active, Direct Thrombin Inhibitor Ximelagatran, an Amidoxime and Ester Prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Drug-induced liver injury in humans: the case of ximelagatran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Prediction of drug-induced liver injury in humans by using in vitro methods: the case of ximelagatran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Functional characterization of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 in healthy Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Molybdenum cofactor-dependent resistance to N-hydroxylated base analogs in Escherichia coli is independent of MobA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Role for CysJ flavin reductase in molybdenum cofactor-dependent resistance of Escherichia coli to 6-N-hydroxylaminopurine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Isolation of diabetes-associated kidney genes using differential display

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Proteomic analysis of 3T3-L1 adipocyte mitochondria during differentiation and enlargement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Biological, clinical and population relevance of 95 loci for blood lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Genome-wide association for methamphetamine dependence: convergent results from 2 samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Genomewide association study of movement-related adverse antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Molybdenum cofactor deficiency presenting as neonatal hyperekplexia: a clinical, biochemical and genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Interstitial deletion 1q42 in a patient with agenesis of corpus callosum: Phenotype-genotype comparison to the 1q41q42 microdeletion suggests a contiguous 1q4 syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

21 January 2018

The molybdenum cofactor

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Molybdenum in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

Dual targeting of mitochondrial proteins: mechanism, regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-014-1216-4

The specific subcellular localization of two isoforms of cytochrome b5 suggests novel targeting pathways

21 January 2018

1 reference

12 December 2020

Demonstration that bovine erythrocyte cytochrome b5 is the hydrophilic segment of liver microsomal cytochrome b5

1 reference

12 December 2020

Characterization of the covalent cross-links of the active sites of amidinated cytochrome b5 and NADH:cytochrome b5 reductase

1 reference

12 December 2020

Anti-Pneumocystis activities of aromatic diamidoxime prodrugs

1 reference

12 December 2020

N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes

1 reference

12 December 2020

Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.

1 reference

12 December 2020

N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the bi

1 reference

12 December 2020

Amidoximes of pentamidine: synthesis, trypanocidal and leishmanicidal activity

1 reference

12 December 2020

Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines

1 reference

12 December 2020

NADH-cytochrome b5 reductase and cytochrome b5 isoforms as models for the study of post-translational targeting to the endoplasmic reticulum

1 reference

12 December 2020

Reduction of N(ω)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC)

1 reference

12 December 2020

Synthesis and anti-Pneumocystis carinii pneumonia activity of novel dicationic dibenzothiophenes and orally active prodrugs

1 reference

12 December 2020

Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate

1 reference

12 December 2020

MOSC domains: ancient, predicted sulfur-carrier domains, present in diverse metal-sulfur cluster biosynthesis proteins including Molybdenum cofactor sulfurases

1 reference

12 December 2020

Metabolism-directed optimisation of antithrombotics: the prodrug principle

1 reference

12 December 2020

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

1 reference

12 December 2020

The mitochondrial amidoxime reducing component (mARC): involvement in metabolic reduction of N-oxides, oximes and N-hydroxyamidinohydrazones

1 reference

12 December 2020

Evidence for the inorganic nature of the cyanolyzable sulfur of molybdenum hydroxylases

1 reference

12 December 2020

One-electron oxidation-reduction properties of hepatic NADH-cytochrome b5 reductase

1 reference

12 December 2020

On the mechanism of inactivation of xanthine oxidase by cyanide

1 reference

12 December 2020

Pentamidine for the prevention and treatment of P. carinii pneumonia

1 reference

12 December 2020

Cytochrome b5-like hemoprotein of outer mitochondrial membrane; OM cytochrome b. I. Purification of OM cytochrome b from rat liver mitochondria and comparison of its molecular properties with those of cytochrome b5

1 reference

12 December 2020

Reduction of amidoxime derivatives to pentamidine in vivo

1 reference

12 December 2020

10.1007/S00775-014-1216-4

Identifiers

DOI

1 reference

1 September 2017

1 reference